Voie d'immunisation et séquence d'administration de l ... - TEL

tel-00827710, version 1 - 29 May 2013
Perez, S.A., von Hofe, E., Kallinteris, N.L., Gritzapis, A.D., Peoples, G.E., Papamichail, M.,
and Baxevanis, C.N. (2010). A new era in anticancer peptide vaccines. Cancer 116, 2071-
2080.
Pestka, S., Krause, C.D., and Walter, M.R. (2004). Interferons, interferon-like cytokines, and
their receptors. Immunol Rev 202, 8-32.
Petersen, T.R., Sika-Paotonu, D., Knight, D.A., Simkins, H.M., and Hermans, I.F. (2011).
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT
cells and CD8+ T cells to dendritic cell-based vaccines. PLoS One 6, e17657.
Platt, C.D., Ma, J.K., Chalouni, C., Ebersold, M., Bou-Reslan, H., Carano, R.A., Mellman, I.,
and Delamarre, L. (2010). Mature dendritic cells use endocytic receptors to capture and
present antigens. Proc Natl Acad Sci U S A 107, 4287-4292.
Plotkin, S.A., and Plotkin, S.L. (2011). The development of vaccines: how the past led to the
future. Nat Rev Microbiol 9, 889-893.
Poulin, L.F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., Chen, J.L., Keller,
A.M., Joffre, O., Zelenay, S., Nye, E., et al. (2010). Characterization of human DNGR-1+
BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med
207, 1261-1271.
Precopio, M.L., Betts, M.R., Parrino, J., Price, D.A., Gostick, E., Ambrozak, D.R., Asher,
T.E., Douek, D.C., Harari, A., Pantaleo, G., et al. (2007). Immunization with vaccinia virus
induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med
204, 1405-1416.
Prlic, M., Hernandez-Hoyos, G., and Bevan, M.J. (2006). Duration of the initial TCR stimulus
controls the magnitude but not functionality of the CD8+ T cell response. J Exp Med 203,
2135-2143.
Qiu, H., Fan, Y., Joyee, A.G., Wang, S., Han, X., Bai, H., Jiao, L., Van Rooijen, N., and
Yang, X. (2008). Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection
by enhancing apoptosis of local macrophages. J Immunol 181, 2092-2102.
Rappuoli, R., and Aderem, A. (2011). A 2020 vision for vaccines against HIV, tuberculosis
and malaria. Nature 473, 463-469.
Ravichandran, K.S. (2011). Beginnings of a good apoptotic meal: the find-me and eat-me
signaling pathways. Immunity 35, 445-455.
Rees, W., Bender, J., Teague, T.K., Kedl, R.M., Crawford, F., Marrack, P., and Kappler, J.
(1999). An inverse relationship between T cell receptor affinity and antigen dose during
CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A 96, 9781-9786.
Rice, J., Ottensmeier, C.H., and Stevenson, F.K. (2008). DNA vaccines: precision tools for
activating effective immunity against cancer. Nat Rev Cancer 8, 108-120.
Rizza, P., Moretti, F., and Belardelli, F. (2010). Recent advances on the immunomodulatory
effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity.
Autoimmunity 43, 204-209.
Russo, V., Cipponi, A., Raccosta, L., Rainelli, C., Fontana, R., Maggioni, D., Lunghi, F.,
Mukenge, S., Ciceri, F., Bregni, M., et al. (2007). Lymphocytes genetically modified to
express tumor antigens target DCs in vivo and induce antitumor immunity. J Clin Invest 117,
3087-3096.
Ryan, E.J., and O'Farrelly, C. (2011). The affect of chronic hepatitis C infection on dendritic
cell function: a summary of the experimental evidence. J Viral Hepat 18, 601-607.
Page 249 of 256